Meclizine is a first-generation antihistamine agent belonging to the piperazine class of H1 receptor antagonists. It is associated with pharmaceutical applications for the symptomatic management of motion sickness, dizziness, nausea, vomiting, and vertigo.
Meclizine exerts its pharmacological activity primarily through histamine H1 receptor antagonism. Its antihistaminic and anticholinergic properties contribute to its antiemetic and antivertigo effects.
Swapnroop Drugs and Pharmaceuticals supplies Meclizine API for qualified pharmaceutical, research, and formulation requirements with emphasis on product traceability, controlled documentation, quality consistency, and secure supply-chain management.
Meclizine API is primarily associated with:
Meclizine is commonly associated with pharmaceutical preparations developed for motion sickness and vertigo-related symptoms.
Meclizine API is supplied in secure, pharmaceutical-grade packaging selected according to product stability, quantity, safety, and customer requirements.
Packaging options and shipment quantities are provided based on approved commercial, quality, and regulatory requirements.
Store Meclizine API in tightly closed, appropriately labeled containers under recommended controlled conditions.
Protect the material from excessive moisture, heat, and direct light. Handling should be performed by trained personnel according to approved pharmaceutical material handling procedures and applicable safety requirements.
Swapnroop Drugs and Pharmaceuticals is committed to supplying pharmaceutical raw materials with a focus on:
As a pharmaceutical raw material supplier in India, Swapnroop Drugs and Pharmaceuticals provides Meclizine API bulk supply and export support for qualified pharmaceutical, research, formulation, and industrial customers.
For Meclizine API price, specification, COA availability, MOQ, packaging, and export enquiries, contact our pharmaceutical sales team.
Email: enquiry@sdp.org.in
Website: www.sdp.org.in